Search

Search Constraints

You searched for: Author/Creator Zhu, Xiaming

Search Results

1. Anti‐CD19 and anti‐BCMA CAR T cell therapy followed by lenalidomide maintenance after autologous stem‐cell transplantation for high‐risk newly diagnosed multiple myeloma. Issue 5 (9th February 2022)

7. Sequential CD19 and BCMA‐specific CAR T‐cell treatment elicits sustained remission of relapsed and/or refractory myeloma. (23rd December 2020)